HIP
EGRX

Hatteras Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Hatteras Investment Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,770
Closed -$882K – 70
2016
Q1 		$882K Buy
21,770
+17,230
+380% +$698K 2.41% 11
2015
Q4 		$403K Buy
+4,540
New +$403K 0.53% 57